1. Home
  2. LGVN vs ILAG Comparison

LGVN vs ILAG Comparison

Compare LGVN & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • ILAG
  • Stock Information
  • Founded
  • LGVN 2014
  • ILAG 1981
  • Country
  • LGVN United States
  • ILAG Hong Kong
  • Employees
  • LGVN N/A
  • ILAG N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • ILAG Office Equipment/Supplies/Services
  • Sector
  • LGVN Health Care
  • ILAG Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • ILAG Nasdaq
  • Market Cap
  • LGVN 30.0M
  • ILAG 18.4M
  • IPO Year
  • LGVN 2021
  • ILAG 2022
  • Fundamental
  • Price
  • LGVN $2.05
  • ILAG $0.98
  • Analyst Decision
  • LGVN Strong Buy
  • ILAG
  • Analyst Count
  • LGVN 2
  • ILAG 0
  • Target Price
  • LGVN $8.00
  • ILAG N/A
  • AVG Volume (30 Days)
  • LGVN 393.9K
  • ILAG 47.1K
  • Earning Date
  • LGVN 11-08-2024
  • ILAG 11-29-2024
  • Dividend Yield
  • LGVN N/A
  • ILAG N/A
  • EPS Growth
  • LGVN N/A
  • ILAG N/A
  • EPS
  • LGVN N/A
  • ILAG N/A
  • Revenue
  • LGVN $1,229,000.00
  • ILAG $6,443,357.00
  • Revenue This Year
  • LGVN $161.78
  • ILAG N/A
  • Revenue Next Year
  • LGVN $8.62
  • ILAG N/A
  • P/E Ratio
  • LGVN N/A
  • ILAG N/A
  • Revenue Growth
  • LGVN 39.34
  • ILAG N/A
  • 52 Week Low
  • LGVN $0.77
  • ILAG $0.33
  • 52 Week High
  • LGVN $23.90
  • ILAG $1.35
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 52.20
  • ILAG 44.56
  • Support Level
  • LGVN $1.76
  • ILAG $0.97
  • Resistance Level
  • LGVN $2.26
  • ILAG $1.06
  • Average True Range (ATR)
  • LGVN 0.12
  • ILAG 0.06
  • MACD
  • LGVN 0.05
  • ILAG -0.01
  • Stochastic Oscillator
  • LGVN 58.00
  • ILAG 16.32

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.

Share on Social Networks: